Stomach Cancer Age 30
Nivolumab In Patients With Advanced Gastric Or Gastro Oesophageal Junction Cancer Refractory To Or Intolerant Of At Least Two Previous Chemotherapy Regimens Ono 4538 12 Attraction 2 A Randomised Double Blind Placebo Controlled Phase 3 Trial The